Next September 8th the most important oncology congress in Europe will take place in Madrid. GENOMICA will present a poster with the results of the study done with its kit CLART® CMA EGFR.
The study titled “Clinical evaluation of low density array based EGFR mutation detecting kit using tissue samples and liquid biopsies” carried out by the Departments of Anatomical Pathology of theUniversity Hospital Vall’Dhebrón in Barcelona and theUniversity Hospital 12 de Octubre in Madrid. The result of the study shows that the kit achieves a sensitivity of 96.5%, a specificity of 100% and has an excellent concordance with other platforms used in hospital practice. An optimal kit for the clinical routine. The poster can be seen by congress attendees on Monday 11th at hall number 8 (1264P).
GENOMICA will have available a space in the PharmaMar’s booth (# 206) where it will provide extended information about its IVD kits from tis oncologic line CLART® CMA.